Hsu-Shan Huang

https://orcid.org/0000-0001-8162-5608

Emailhuanghs99@tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

1996 Dr.rer.nat., Institute of Pharmacy, University of Regensburg, Germany
1987 Master, Institute of Pharmacy, National Defense Medical Center
1985 Bachelor, School of Pharmacy, National Defense Medical Center

Experience

2019- Professor, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University
2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
2018- Professor, Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University
2016-2017 Professor,Ph.D. Program in Biotechnology Research and Development, Taipei Medical University.
2014-2018 Professor, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University.
2013-2014 Professor, Department of Pharmaceutical Sciences, Taipei Medical University.
2013-2013 Professor, School of Pharmacy, Taipei Medical University.
2006-2007 Professor, Graduate Institute of Pharmacognosy, Taipei Medical University.
2002-2006 Associate Professor, Graduate Institute of Pharmacognosy, Taipei Medical University.

Awards

Editorial Board:
International Journal of Advanced Chemistry (IJAC)
International Journal of Organic Chemistry
Der Pharma Chemica
Journal of Chemical Science and Technology
Advances in Organic Chemistry (AOC)
Journal of Bone Marrow and Stem Cell Research
Journal of Natural Products Research Updates
Innovational: Journal of Chemistry (IJChem)
International Journal of Biological Instrumentation
Asian Council of Science
Editorial Advisory Board:
The Open Cancer Journal (ISSN: 1874-0790)
Recent Patent Reviews on Anti-cancer Drug Discovery
Outstanding reviewer:
Outstanding reviewer: Bioorganic & Medicinal Chemistry
Outstanding reviewer: European Journal of Medicinal Chemistry

Research Interests

New drugs discovery and development
Medicinal chemistry
Discovery of novel anticancer drugs
Discovery of novel anti-inflammatory drugs

URL

https://scholar.google.com.tw/citations?hl=zh-TW&user=llIgOqYAAAAJ&view_op=list_works&sortby=pubdate

Fingerprint

Dive into the research topics where Hsu-Shan Huang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Active
7 Finished

治療膠質母細胞瘤之新穎小分子多標靶抗癌藥物之設計合成與開發
Huang, H.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
New Development Strategy for Novel Multitarget Anticancer Drug Discovery through Artificial Intelligence (Ai) and Machine Learning (Ml) Model
Huang, H.
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Fragment-Based Discovery of First-In-Class Small-Molecule Kinase Inhibitors for Targeted Cancer Therapies(2/2)
Huang, H.
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
Fragment-Based Discovery of First-In-Class Small-Molecule Kinase Inhibitors for Targeted Cancer Therapies( I )( I )
Huang, H.
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
Development of Novel Tetracyclic and Heterocyclic Dual Topoisomerases Inhibitors as Anticancer Agents( II )
Huang, H.
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology

1272 Citations
21 h-Index
95 Article
32 Patent

A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway
Hsieh, C-L., Huang, H-S., Chen, K-C., Saka, T., Chiang, C-Y., Chung, L. W. K. & Sung, S-Y., Jan 1 2020, In: Molecular Cancer Therapeutics. 19, 1, p. 101-111 11 p.
Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
CC12 induces apoptotic cell death and cell cycle arrest in human glioblastoma cell lines and mouse xenograft model
Fann, L. Y., Shih, J. H., Tseng, J. H., Huang, H. S. & Hsiao, S. H., Apr 2020, In: Molecules. 25, 8, 25081793.
Research output: Contribution to journal › Article › peer-review

Open Access
Hnc0014, a multi-targeted small-molecule, inhibits head and neck squamous cell carcinoma by suppressing c-met/stat3/cd44/pd-l1 oncoimmune signature and eliciting antitumor immune responses
Lee, J. C., Wu, A. T. H., Chen, J. H., Huang, W. Y., Lawal, B., Mokgautsi, N., Huang, H. S. & Ho, C. L., Dec 2020, In: Cancers. 12, 12, p. 1-18 18 p., 3759.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
Preclinical evaluation of the novel small-molecule msi-n1014 for treating drug-resistant colon cancer via the lgr5/β-catenin/mir-142-3p network and reducing cancer-associated fibroblast transformation
Yadav, V. K., Huang, Y. J., George, T. A., Wei, P. L., Sumitra, M. R., Ho, C. L., Chang, T. H., Wu, A. T. H. & Huang, H. S., Jun 16 2020, In: Cancers. 12, 6, p. 1-15 15 p., 1590.
Research output: Contribution to journal › Article › peer-review

Open Access
TDAG8 deficiency reduces satellite glial number and pro-inflammatory macrophage number to relieve rheumatoid arthritis disease severity and chronic pain
Dai, S. P., Hsieh, W. S., Chen, C. H., Lu, Y. H., Huang, H. S., Chang, D. M., Huang, S. L. & Sun, W. H., May 29 2020, In: Journal of Neuroinflammation. 17, 1, 170.
Research output: Contribution to journal › Article › peer-review

Open Access